Bio-Inspired Green Synthesis of Nanoparticles for Psoriasis Treatment: A Review of Current Status and Future Directions

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 56

فایل این مقاله در 31 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AJGC-9-4_002

تاریخ نمایه سازی: 1 اردیبهشت 1404

چکیده مقاله:

Psoriasis is a chronic autoimmune skin disorder characterized by inflammation, keratinocyte hyperproliferation, and immune system dysregulation, which pose significant challenges to effective management. Recent advances in nanotechnology have shown promise in revolutionizing psoriasis treatment by enabling targeted drug delivery, enhanced bioavailability, and reduced systemic side effects. Green synthesis of nanoparticles is gaining popularity because it is environmentally friendly, affordable, and sustainable. It uses natural materials like plants, microbes, and biomolecules. This review explores the current status of bioinspired green synthesis techniques for nanoparticles and their applications in psoriasis treatment. The principles of green synthesis, along with commonly used biological sources such as plant-based materials, microbial systems, and enzymes, are discussed in detail. The mechanisms of action, along with the potential and benefits of metallic, polymeric, and composite nanoparticles, have been studied in detail for treating the complex pathophysiology of psoriasis. This article explores novel green synthesis approaches together with nanoparticle identification methods and explains the present trends that include diverse nanocomplex capabilities with custom treatments and machine intelligence systems for therapeutic nanoparticles. The promise of green-synthesized nanoparticles is hindered by major obstacles such as scalability, stability, and environmental issues. This review highlights the future approaches that should focus on creating and maintaining effective patient-focused nanotherapeutics to treat psoriasis, while also pointing out the need for interdisciplinary research to achieve successful clinical implementation.

نویسندگان

Uppuluri Varuna Naga Venkata Arjun

Department of Pharmaceutics, Vels Institute of Science, Technology and Advanced Studies (VISTAS), PV Vaithiyalingam Rd, Velan Nagar, Krishna puram, Pallavaram, Chennai, ۶۰۰ ۱۱۷, Tamil Nadu, India

Nithin Vidiyala

Principal Scientist, Cerevel therapeutics, ۲۲۲ Jacobs St. Suite ۲۰۰, Boston, Massachusetts ۰۲۱۴۱, USA

Pavani Sunkishala

Senior Validation Specialist at PCI Pharma Services,۲۳ Commerce Drive, Bedford, NH, ۰۳۱۱۰, US

Pradeep Vidiyala

Manager Analytical Chemistry, Elixir Medical Corporation, ۹۲۰ N McCarthy Blvd #۱۰۰, Milpitas, CA ۹۵۰۳۵, US

Konatham Teja Kumar Reddy

Department of Pharmacy, University College of Technology, Osmania University, Amberpet, Hyderabad, Telangana ۵۰۰۰۰۷, India

Selvaraja Elumalai

Department of Chemistry, Raffles University, Neemrana, Alwar, Rajasthan ۳۰۱۷۰۵, India

Sonam Bhutia

Department of Pharmacy, Government Pharmacy College Sajong, Government of Sikkim, Sikkim University, India

Sabeena Syed

School of Pharmacy, Vishwakarma University, Betal Nagar, Kondhwa, Pune, Maharashtra ۴۱۱۰۴۸, India

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :